Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/9724

Title:	Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply.
Authors:	Bernal, T Martínez-Camblor, P Sánchez-García, J Sanz, G
metadata.dc.subject.mesh:	Antimetabolites, Antineoplastic Azacitidine Female Humans Male Myelodysplastic Syndromes
Issue Date:	12-Jan-2016
URI:	http://hdl.handle.net/10668/9724
metadata.dc.identifier.doi:	10.1038/leu.2015.339
Appears in Collections:	Producción 2020

Files in This Item:

There are no files associated with this item.

This item is protected by original copyright

Show full item record Recommend this item

This item is licensed under a Creative Commons License

RISalud